Lantern Pharma Inc.

LTRN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.45

-$0.05 (-3.33%)

Sep 22, 2026, 11:56 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.33%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Weak

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $18.5M

1D Range

1.41 1.64

52W Range

1.11 4.70

Valuation (TTM)

PE -0.93

PB -5.95

EV/EBITDA -1.03

Valuation (NTM)

Forward PE N/A

Forward PEG -0.04

Price Target N/A

Cash Flow

FCF Yield -73.6%

SBC Adj. FCF Yield -78.2%

SBC Impact -6.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 0.9% | -4.9%

FCF 3Y | 5Y 3.8% | -4.3%

Returns

ROA -216.8%

ROE -456.4%

ROIC -358.0%

Financial Health

Net Cash

$7.32M

Current Ratio 1.96

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensi...

Sector Healthcare

Industry Biotechnology

Employees 16

IPO Date Jun 10, 2020

Website www.lanternpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.